Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-02 Sale | 2022-09-07 4:26 pm | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY CFO | 15,355 | $39.57 | $607,597 | 0 (Direct) | View |
| 2022-08-31 Sale | 2022-09-02 4:27 pm | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON VP | 65,231 | $38.31 | $2,499,023 | 16,796 (Direct) | View |
| 2022-08-12 Sale | 2022-08-16 5:36 pm | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. VP | 57,743 | $38.31 | $2,211,978 | 10,000 (Direct) | View |
| 2022-08-12 Sale | 2022-08-16 5:31 pm | Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director | 177,135 | $38.25 | $6,775,149 | 6,000 (Direct) | View |
| 2022-03-08 Sale(A) | 2022-03-08 9:41 pm | Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director | 2,500 | $30.8 | $77,000 | 193,135 (Direct) | View |
| 2022-03-04 Sale | 2022-03-08 7:58 pm | Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director | 54,962 | $29.28 | $1,609,321 | 183,135 (Direct) | View |
| 2022-03-04 Sale | 2022-03-08 7:35 pm | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON VP | 21,710 | $30.5 | $662,208 | 17,232 (Direct) | View |
| 2022-03-04 Sale | 2022-03-08 7:32 pm | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. VP | 51,168 | $30.63 | $1,567,394 | 10,000 (Direct) | View |
| 2022-01-21 Purchase | 2022-01-21 5:04 pm | Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer | 700 | $28.81 | $20,167 | 700 (Direct) | View |
| 2021-12-06 Purchase | 2021-12-07 4:13 pm | Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer | 4,000 | $24.4 | $97,600 | 4,000 (Direct) | View |
| 2021-11-15 Sale | 2021-11-16 8:40 pm | Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director | 17,557 | $31.33 | $550,061 | 210,186 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-09-02 Exercise | 2022-09-07 4:26 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY CFO | 813 | $8.4 | 0 (Direct) | View |
| 2022-09-02 Exercise | 2022-09-07 4:26 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY CFO | 32 | $7.49 | 0 (Direct) | View |
| 2022-09-02 Exercise | 2022-09-07 4:26 pm | N/A 2029-09-15 | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY CFO | 18,648 | $0 | 0 (Direct) | View |
| 2022-09-02 Exercise | 2022-09-07 4:26 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY CFO | 2,292 | $3.1 | 0 (Direct) | View |
| 2022-09-02 Tax Withholding | 2022-09-07 4:26 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY CFO | 3,293 | $39.53 | 0 (Direct) | View |
| 2022-09-02 Exercise | 2022-09-07 4:26 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY CFO | 9,000 | $9.44 | 0 (Direct) | View |
| 2022-09-02 Exercise | 2022-09-07 4:26 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY CFO | 6,511 | $4.75 | 0 (Direct) | View |
| 2022-08-31 Tax Withholding | 2022-09-02 4:27 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON VP | 1,572 | $37.86 | 16,796 (Direct) | View |
| 2022-08-31 Exercise | 2022-09-02 4:27 pm | N/A 2022-12-31 | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON VP | 72,488 | $0 | 16,796 (Direct) | View |
| 2022-08-31 Tax Withholding | 2022-09-02 4:27 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON VP | 6,121 | $38.81 | 16,796 (Direct) | View |
| 2022-08-31 Exercise | 2022-09-02 4:27 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON VP | 17,488 | $2.67 | 16,796 (Direct) | View |
| 2022-08-31 Exercise | 2022-09-02 4:27 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON VP | 55,000 | $4.75 | 16,796 (Direct) | View |
| 2022-08-12 Exercise | 2022-08-16 5:36 pm | N/A 2027-10-22 | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. VP | 65,000 | $0 | 10,000 (Direct) | View |
| 2022-08-12 Exercise | 2022-08-16 5:36 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. VP | 20,000 | $3.1 | 10,000 (Direct) | View |
| 2022-08-12 Tax Withholding | 2022-08-16 5:36 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. VP | 7,257 | $38.02 | 10,000 (Direct) | View |
| 2022-08-12 Exercise | 2022-08-16 5:36 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. VP | 45,000 | $4.75 | 10,000 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-29 5:48 pm | N/A 2032-06-27 | Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-29 5:44 pm | N/A 2032-06-27 | Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-29 5:40 pm | N/A 2032-06-27 | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-29 5:34 pm | N/A 2032-06-27 | Xenon Pharmaceuticals Inc. | XENE | Machado Patrick Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-29 5:31 pm | N/A 2032-06-27 | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-29 5:26 pm | N/A 2032-06-27 | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-29 5:23 pm | N/A 2032-06-27 | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:24 pm | N/A 2032-03-09 | Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:21 pm | N/A 2032-03-09 | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON VP | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:20 pm | N/A 2032-03-09 | Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Chairman | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:15 pm | N/A 2032-03-09 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN CEO | 400,000 | $0 | 400,000 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:13 pm | N/A 2032-03-09 | Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:11 pm | N/A 2032-03-09 | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY CFO | 125,000 | $0 | 125,000 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:10 pm | N/A 2032-03-09 | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. VP | 65,000 | $0 | 65,000 (Direct) | View |
| 2022-03-04 Exercise | 2022-03-08 7:58 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director | 30,864 | $3.67 | 183,135 (Direct) | View |
| 2022-03-04 Tax Withholding | 2022-03-08 7:58 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director | 963 | $31.42 | 183,135 (Direct) | View |
| 2022-03-04 Exercise | 2022-03-08 7:58 pm | N/A 2022-03-10 | Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director | 30,864 | $0 | 183,135 (Direct) | View |
| 2022-03-04 Tax Withholding | 2022-03-08 7:58 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director | 1,990 | $30.23 | 183,135 (Direct) | View |
| 2022-03-04 Exercise | 2022-03-08 7:35 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON VP | 7,406 | $3.67 | 17,232 (Direct) | View |
| 2022-03-04 Tax Withholding | 2022-03-08 7:35 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON VP | 696 | $31.42 | 17,232 (Direct) | View |
| 2022-03-04 Exercise | 2022-03-08 7:35 pm | N/A 2022-03-10 | Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON VP | 7,406 | $0 | 17,232 (Direct) | View |
| 2022-03-04 Exercise | 2022-03-08 7:32 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. VP | 27,500 | $8.4 | 10,000 (Direct) | View |
| 2022-03-04 Exercise | 2022-03-08 7:32 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. VP | 40,000 | $6.76 | 10,000 (Direct) | View |
| 2022-03-04 Tax Withholding | 2022-03-08 7:32 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. VP | 6,685 | $31.42 | 10,000 (Direct) | View |
| 2022-03-04 Exercise | 2022-03-08 7:32 pm | N/A 2027-03-12 | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. VP | 67,500 | $0 | 10,000 (Direct) | View |
| 2022-03-04 Tax Withholding | 2022-03-08 7:32 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. VP | 9,647 | $30.23 | 10,000 (Direct) | View |
| 2021-12-15 Exercise | 2021-12-17 4:04 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 3,086 | $3.67 | 66,819 (Direct) | View |
| 2021-12-15 Exercise | 2021-12-17 4:04 pm | N/A 2021-12-31 | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 3,086 | $0 | 66,819 (Direct) | View |
| 2021-12-08 Exercise | 2021-12-10 4:20 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 2,057 | $3.67 | 38,130 (Direct) | View |
| 2021-12-08 Exercise | 2021-12-10 4:20 pm | N/A 2021-12-31 | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 2,057 | $0 | 38,130 (Direct) | View |
| 2021-08-23 Option Award | 2021-08-25 4:12 pm | N/A 2031-08-22 | Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2021-08-23 Ownership | 2021-08-25 4:05 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer | 0 | $0 | 0 (Direct) | View |
| 2021-03-17 Acquisition | 2021-06-04 7:20 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 100 | $19.49 | 46,173 (Indirect) | View |
| 2021-03-17 Option Award | 2021-06-04 7:20 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director | 10,000 | $0 | 46,173 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-03 9:16 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-03 9:09 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | Machado Patrick Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-03 9:07 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | Hayden Michael R Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-03 9:04 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-03 9:02 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-03 9:00 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-06-03 Ownership | 2021-06-03 8:57 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 0 | $0 | 0 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-03 4:46 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN CEO | 125,000 | $0 | 125,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-03 4:42 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY CFO | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-06-03 Ownership | 2021-06-03 4:35 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY CFO | 0 | $0 | 71,982 (Direct) | View |